tiprankstipranks
Trending News
More News >
BioAtla (BCAB)
NASDAQ:BCAB
US Market

BioAtla (BCAB) Financial Statements

Compare
542 Followers

BioAtla Financial Overview

BioAtla's market cap is currently $17.77M. The company's EPS TTM is $-1.437; its P/E ratio is ―; BioAtla is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 250.00K$ 429.00K
Gross Profit$ 0.00$ -103.73M$ -1.20M$ -1.08M$ 409.07K
Operating Income$ -73.94M$ -129.69M$ -108.14M$ -96.44M$ -30.10M
EBITDA$ -73.94M$ -122.24M$ -106.48M$ -94.07M$ -33.46M
Net Income$ 0.00$ -123.46M$ -105.28M$ -95.41M$ -37.24M
Balance Sheet
Cash & Short-Term Investments$ 49.05M$ 111.47M$ 215.51M$ 244.98M$ 238.60M
Total Assets$ 52.42M$ 119.66M$ 225.74M$ 254.42M$ 244.94M
Total Debt$ 836.00K$ 2.46M$ 3.98M$ 5.37M$ 682.00K
Net Debt$ -48.21M$ -109.01M$ -211.53M$ -239.61M$ -237.92M
Total Liabilities$ 38.16M$ 48.99M$ 45.40M$ 43.60M$ 34.96M
Stockholders' Equity$ 14.27M$ 70.67M$ 180.34M$ 210.82M$ 209.97M
Cash Flow
Free Cash Flow$ -71.94M$ -104.11M$ -90.69M$ -63.14M$ -36.92M
Operating Cash Flow$ -71.94M$ -104.02M$ -90.42M$ -62.21M$ -36.33M
Investing Cash Flow$ 0.00$ -98.00K$ -265.00K$ -924.00K$ -590.00K
Financing Cash Flow$ 9.51M$ 77.00K$ 61.21K$ 69.51M$ 271.82M
Currency in USD

BioAtla Earnings and Revenue History

BioAtla Debt to Assets

BioAtla Cash Flow

BioAtla Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis